A patient on escitalopram (Lexapro) with added bupropion (Wellbutrin) 300 mg daily continues to have low libido; how should I manage the persistent sexual dysfunction?

Management of Persistent Low Libido Despite Bupropion Addition

You should switch from escitalopram to bupropion monotherapy rather than continuing the combination, as bupropion has significantly lower sexual dysfunction rates (8-10%) compared to escitalopram, and the SSRI is likely the primary driver of the persistent libido problem. 1, 2

Why the Current Strategy Is Failing

• Escitalopram, like all SSRIs, causes sexual dysfunction through multiple mechanisms including decreased libido, delayed orgasm, and reduced genital sensation, with real-world rates substantially higher than reported in trials 1
• Adding bupropion 300 mg to an SSRI addresses only part of the problem—the SSRI continues to actively suppress sexual function even with bupropion augmentation 3, 4
• The evidence for bupropion as an "antidote" when added to ongoing SSRIs is mixed: one open-label study showed 46-75% response rates 3, but a placebo-controlled trial found bupropion SR 150 mg daily was no better than placebo for SSRI-induced sexual dysfunction 5

Recommended Treatment Algorithm

Step 1: Switch to Bupropion Monotherapy

• Discontinue escitalopram gradually (taper over 10-14 days to limit withdrawal symptoms) while simultaneously starting or continuing bupropion 1
• Target bupropion dose: 300-400 mg/day for optimal antidepressant efficacy, as 150 mg daily has shown insufficient benefit in controlled trials 2, 5
• Bupropion demonstrates comparable antidepressant efficacy to SSRIs but with dramatically lower sexual dysfunction rates (8-10% vs. 40-70% for SSRIs) 1, 2, 6

Step 2: Monitor Response Within 2-4 Weeks

• Most improvement in sexual function occurs within the first 2 weeks of bupropion treatment at doses of 100-200 mg/day, with further benefit at higher doses 3
• Assess both depressive symptoms and sexual function (libido, arousal, orgasm) at 1-2 weeks and again at 6-8 weeks 1, 2

Step 3: If Depression Control Is Inadequate on Bupropion Alone

• Consider mirtazapine 15-30 mg/day as an alternative, which has lower sexual dysfunction rates than SSRIs but causes sedation and weight gain 1
• If an SSRI must be used due to comorbid anxiety, avoid paroxetine entirely (70.7% sexual dysfunction rate) and consider sertraline or citalopram as less problematic options 1, 2

Critical Safety Considerations

• Bupropion increases seizure risk, particularly at doses >300 mg/day or in patients with eating disorders, history of seizures, or abrupt alcohol/benzodiazepine discontinuation 2, 6
• Do not use bupropion in agitated patients or those with seizure disorders 1
• Monitor for discontinuation symptoms when tapering escitalopram, including dizziness, paresthesias, anxiety, and flu-like symptoms 2

Adjunctive Strategies If Switching Is Not Feasible

If the patient cannot discontinue escitalopram due to superior depression/anxiety control:

• Add a PDE5 inhibitor (sildenafil or tadalafil) if erectile dysfunction coexists with low libido, though these primarily address erectile function rather than desire 1, 2
• Check morning testosterone levels (target >300 ng/dL), as low testosterone contributes to decreased libido independent of SSRI effects 1
• Consider non-pharmacologic interventions: vibratory therapy for loss of genital sensation, pelvic physical therapy for co-existing pelvic floor dysfunction, and sex therapy or couples counseling 1

Common Pitfalls to Avoid

• Do not use buspirone—despite its mention in some guidelines, the American College of Physicians explicitly recommends against it for SSRI-induced sexual dysfunction due to lack of evidence 1
• Do not assume the current dose of bupropion is adequate—the failed placebo-controlled trial used only 150 mg daily, and higher doses (300-400 mg) may be necessary 5, 2
• Do not underestimate the persistence of SSRI effects—sexual dysfunction from SSRIs is dose-related and will continue as long as the SSRI is maintained, regardless of augmentation strategies 1